| 000 | 01795 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513031324.0 | ||
| 264 | 0 | _c19950120 | |
| 008 | 199501s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGerhartz, H H | |
| 245 | 0 | 0 |
_aRecombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cDec 1994 |
||
| 300 |
_a25-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 |
_aProcarbazine _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aEngelhard, M | |
| 700 | 1 | _aBrittinger, G | |
| 700 | 1 | _aSchlimok, G | |
| 700 | 1 | _aThiel, E | |
| 700 | 1 | _aHuber, C | |
| 700 | 1 | _aEmmerich, B | |
| 700 | 1 | _aSchadek, C | |
| 700 | 1 | _aBrandmaier, R | |
| 700 | 1 | _aStern, A C | |
| 773 | 0 |
_tSeminars in oncology _gvol. 21 _gno. 6 Suppl 16 _gp. 25-8 |
|
| 999 |
_c7527910 _d7527910 |
||